Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Extension granted for addiction treatment and stimulants via telehealth
Health and Wellness

Extension granted for addiction treatment and stimulants via telehealth

Last updated: November 16, 2024 1:30 am
Share
Extension granted for addiction treatment and stimulants via telehealth
SHARE

Federal officials announced on Friday that health providers will be able to continue prescribing drugs for opioid addiction and ADHD over telehealth for another year, ending a lengthy debate among policymakers. The temporary rules issued by the Drug Enforcement Agency during the pandemic allowed providers to prescribe controlled substances such as buprenorphine and Adderall without an initial in-person meeting, and were set to expire on January 1. The extension until the end of 2025 comes after months of uncertainty and nearly 40,000 comments on proposed rules.

The pandemic flexibilities opened up discussions about the strict regulations that some believe hinder access to vital treatments. It also led to the rise of telehealth companies that offered care under the relaxed rules. However, in 2023, the DEA introduced draft rules to reinstate restrictions, which received backlash from telehealth advocates and providers. Last October, the agency extended the flexibilities until the end of this year, delaying the resolution of the ongoing debate.

The leaked draft rules included stringent restrictions, such as requiring half of a provider’s controlled substance prescriptions to be written for patients seen in person and mandating providers to check patients against prescription drug monitoring programs in all 50 states. Telehealth companies raised concerns that these regulations would be unsustainable and could lead to the closure of some services. Due to inter-agency conflicts and political reasons, the DEA did not meet its promise to issue final rules by the fall.

The temporary extension was seen as a response to concerns about companies overprescribing stimulants for profit, with recent arrests of leaders from an ADHD-focused telehealth company fueling these suspicions. While acknowledging the need for oversight to prevent fraudulent practices, telehealth companies stressed the importance of continuing progress in opioid addiction care. The extension specifically mentioned the urgent public health need for continued access to buprenorphine for opioid use disorder treatment.

See also  UnitedHealth used HRAs, chart review to boost Medicare Advantage profits

Despite the celebration of the extension by proponents of buprenorphine access, many believe that it is still a temporary measure and insufficient in the long run. Stephanie Strong, CEO of telehealth addiction medicine company Boulder Care, emphasized that telehealth is not just a temporary solution but a crucial necessity. The extension of telehealth policies is just one of several expiring at the end of the year, with Congress considering legislation to extend rules allowing Medicare enrollees to receive a wide range of services over telehealth for two more years.

As the telehealth landscape continues to evolve, stakeholders are advocating for a balance between ensuring patient access to essential treatments and safeguarding against misuse and fraudulent practices. The extension of the telehealth prescription rules offers a temporary reprieve, but the need for long-term solutions and comprehensive policies remains a pressing concern.

TAGGED:AddictionExtensionGrantedstimulantsviatelehealthTreatment
Share This Article
Twitter Email Copy Link Print
Previous Article Mike Tyson’s many eras: From ‘Iron Mike’ to prison to Holyfield to a Jake Paul bout Mike Tyson’s many eras: From ‘Iron Mike’ to prison to Holyfield to a Jake Paul bout
Next Article ‘AI Granny’ is happy to talk with phone scammers all day ‘AI Granny’ is happy to talk with phone scammers all day
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Study sheds light on non-urgent visits to emergency departments

Emergency departments in the United States are inundated with over 140 million visits annually, costing…

March 20, 2025

Feds charge man who allegedly displayed, fired machine gun on social media

A 22-year-old Chicago man, Latavion Johnson, is facing federal gun charges after allegedly displaying illegal…

October 24, 2024

Ultimate Finance refreshes brand identity to boost growth

Ultimate Finance, a leading asset-based lender based in the UK, has recently unveiled its updated…

June 24, 2025

Drunk NJ sisters arrested after meltdown for being kicked off Frontier Airlines flight, attacking worker: bodycam footage

Two intoxicated sisters from New Jersey allegedly assaulted a Frontier Airlines gate agent after being…

October 9, 2025

Why Autism May Not Be One Condition, But Many

Autism has long been viewed as a spectrum disorder, with a wide range of traits…

July 21, 2025

You Might Also Like

Medicare, midterm elections, Vinay Prasad: Morning Rounds
Health and Wellness

Medicare, midterm elections, Vinay Prasad: Morning Rounds

October 31, 2025
Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
Once Again A Blood Pressure Medication Recall For Cancer Concerns
Health and Wellness

Once Again A Blood Pressure Medication Recall For Cancer Concerns

October 31, 2025
IVF research, FDA vouchers, dementia: Morning Rounds
Health and Wellness

IVF research, FDA vouchers, dementia: Morning Rounds

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?